Person profile
Public information reviewedOtis Brawley, M.D.
Board role
Director · Lyell Immunopharma, Inc. (NASDAQ: LYEL)
Board role
Director · PDS Biotechnology Corp (NASDAQ: PDSB)
Lyell Immunopharma, Inc. (NASDAQ: LYEL)
Director · Current mandate
Director · Board
- Public sources
- 5 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 16, 2026

